A new triterpene glycoside from the stems of Lagerstroemia indica
1
13
D). Fraction A (2.2 g) was chromatographed on a silica gel
5 5
Table 1 H- and C-NMR data of compound 1 in C D N
column eluted with CHCl /MeOH (60:1 to 1:1) to yield
3
Position
d
H
d
C
Position
d
H
d
C
four fractions (A1–A4). Fraction A2 (1.0 g) was separated
over a RP-C18 open column (230–400 mesh, 150 g) with a
solvent system of 100 % MeOH to obtain seven subfrac-
tions (A21–A27). Subfraction A25 (35 mg) was purified by
1
2.41 m, 1.30 m 50.5 19
2.69 m
–
50.0
72.3
30.8
36.9
28.9
19.2
19.5
17.7
15.7
2
4.27 m
3.42 d (9.0)
–
69.1 20
84.3 21
40.8 22
56.6 23
68.0 24
3
2.21 m
semi-preparative reversed-phase HPLC using
a
4
2.13 m, 1.65 m
1.45 s
2
2
50 9 10 mm i.d., 10 lm, Econosil RP-C18 column
Alltech) with a solvent system of 97 % MeOH (1 L, flow
rate; 2 mL/min) to isolate compounds 3 (5 mg, yield
.00167 %) and 8 (4 mg, yield 0.00134 %). Subfraction
5
1.09 m
4.81 brs
(
6
1.76 s
7
1.98 m, 1.77 m 42.9 25
1.62 s
0
8
–
44.0 26
52.1 27
38.7 28
22.4 29
1.86 s
A26 (15 mg) was purified by semi-preparative reversed-
phase HPLC with a solvent system of 97 % MeOH to
afford compound 4 (3 mg, yield 0.001 %). Fraction A4
9
1.65 m
–
1.13 s
10
11
12
–
175.6
31.6
27.3
95.5
74.2
79.4
71.2
78.9
62.2
13
1.78 m
1.75 m
3.01 m
–
1.43 s
(
900 mg) was separated over a RP-C18 open column
230–400 mesh, 150 g) with a solvent system of 90 %
29.2 30
1.36 s
(
0
1
1
1
1
1
1
3
4
5
6
7
8
37.9
41.1
30.8
1
2
3
4
5
6
6.44 d (8.5)
4.21 m
4.05 m
4.40 m
4.32 m
4.44 m
MeOH to obtain five subfractions (A41–A45). Subfraction
A44 (10 mg) and A45 (17 mg) were purified by semi-
preparative reversed-phase HPLC with a solvent system of
0
0
0
0
0
2.38 m
2.73 m, 1.60 m 32.6
7
0 % MeOH to afford compounds 6 (4 mg, yield
.00134 %) and 9 (3 mg, yield 0.001 %), respectively.
The EtOAc fraction (8.9 g) was separated over a RP-C18
–
57.1
49.1
0
2.02 m
1
NMR data were obtained at 700 MHz for H and 175 MHz for
C
open column (230–400 mesh, 300 g) with a solvent system
of 30–100 % MeOH to obtain ten fractions (A–J). Fraction
E (1.0 g) was chromatographed on a Sephadex LH-20
column (450 g, 3 9 90 cm) and eluted with 80 % MeOH
to yield five subfractions (E1–E5). Subfraction E2
H-2), 2.91 (1H, d, J = 10.0 Hz, H-3), 1.17 (3H, s, Me-23),
1
3
.02 (3H, s, Me-27), 1.01 (3H, s, Me-24), 0.95 (3H, s, Me-
(
220 mg) was chromatographed on a Sephadex LH-20
0), 0.91 (3H, s, Me-25), 0.82 (3H, s, Me-26), 0.81 (3H, s,
13
column (80 % MeOH) and purified by semi-preparative
reversed-phase HPLC with a solvent system of 40 %
MeCN to afford compound 1 (9 mg, yield 0.003 %).
Subfraction E3 (22 mg) was applied to LPLC on a
LiChroprep Lobar-A RP-C18 column eluted with 80 %
MeOH and purified by semi-preparative reversed-phase
HPLC with a solvent system of 70 % MeOH to afford
compound 5 (7 mg, yield 0.00234 %). Fraction F (470 mg)
was separated over a RP-C18 open column (230–400 mesh,
Me-29); C-NMR (500 MHz, CD OD) d 179.0 (C-28),
1
3
44.4 (C-13), 121.7 (C-12), 83.2 (C-3), 68.0 (C-2), 55.4 (C-
5
), 47.7 (C-9), 47.3 (C-1), 46.2 (C-17), 46.0 (C-19), 41.7
(
C-14), 41.5 (C-18), 39.4 (C-4), 39.3 (C-8), 38.0 (C-10),
3.8 (C-21), 32.8 (C-7, 29), 32.7 (C-22), 30.5 (C-20), 28.9
C-23), 27.8 (C-15), 25.7 (C-27), 23.5 (C-11), 23.3 (C-16,
0), 18.4 (C-6), 17.2 (C-26), 17.1 (C-24), 16.4 (C-25);
3
(
3
?
FAB-MS m/z 473 [M?H] .
3
b,23-Dihydroxy-1-oxo-olean-12-en-28-oic acid (10):
1
00 g) with a solvent system of 70–100 % MeOH and
1
colorless gum, H-NMR (500 MHz, C D N) d 5.50 (1H, t,
5
5
purified by semi-preparative reversed-phase HPLC (55 %
MeCN) to afford compound 2 (25 mg, yield 0.00834 %).
Fraction G (40 mg) was purified by semi-preparative
reversed-phase HPLC with a solvent system of 60 %
MeCN to afford compounds 7 (2 mg, yield 0.00067 %) and
J = 3.5 Hz, H-12), 4.55 (1H, dd, J = 12.0, 5.0 Hz, H-3),
.12 (1H, d, J = 11.0 Hz, H-23a), 3.71 (1H, d,
J = 11.0 Hz, H-23b), 3.44 (1H, t, J = 12.0 Hz, H-2b),
.26 (1H, dd, J = 14.0, 4.0 Hz, H-18b), 2.79 (1H, dd,
J = 11.5, 5.0 Hz, H-2a), 2.72 (1H, dt, J = 18.0, 5.5,
.5 Hz, H-11a), 2.65 (1H, dd, J = 11.0, 6.0 Hz, H-9), 1.36
4
3
1
0 (2 mg, yield 0.00067 %).
4
2
D
5
Compound (1): colorless gum, ½a —8.5 (c 0.09,
(3H, s, Me-25), 1.23 (3H, s, Me-27), 1.17 (3H, s, Me-24),
MeOH); IR (KBr) m
2973, 2944, 2870, 2830, 1707,
1.08 (3H, s, Me-26), 0.99 (3H, s, Me-30), 0.93 (3H, s, Me-
13
max
1
-
052, 1032, 1022 cm ; H NMR (700 MHz, C D N) and
1
1
29); C-NMR (500 MHz, C D N) d 212.9 (C-1), 179.8 (C-
5
5
5 5
1
3
C NMR (175 MHz, C D N) data, see Table 1; HR-FAB-
5
28), 143.9 (C-13), 123.1 (C-12), 72.6 (C-3), 65.8 (C-23),
52.2 (C-10), 47.2 (C-5), 46.6 (C-17), 45.9 (C-19), 44.9 (C-
2), 43.6 (C-4), 42.2 (C-18), 42.0 (C-14), 39.5 (C-8), 39.4
(C-9), 34.1 (C-21), 33.1 (C-29), 32.9 (C-22), 32.7 (C-7),
30.7 (C-20), 28.1 (C-15), 25.8 (C-27), 25.5 (C-11), 23.6 (C-
5
?
MS 691.4033 m/z [M ? Na] (calcd for C H O Na,
3
6 60 11
6
91.4033).
Maslinic acid (9): colorless gum, H-NMR (500 MHz,
CD OD) d 5.27 (1H, t, J = 3.5 Hz, H-12), 3.62 (1H, m,
1
3
123